November 15, 5:40 AM
Gainers Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
September 23, 4:10 PM
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the “Company”), a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies for a broad range of
August 12, 4:41 PM
SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(0.30) per share. This is a 54.55 percent increase over losses of $(0.66) per share from the same period last year.
Cantor Fitzgerald Initiates Coverage On SELLAS Life Sciences Gr with Overweight Rating, Announces Price Target of $18
July 21, 7:24 AM
Cantor Fitzgerald initiates coverage on SELLAS Life Sciences Gr (NASDAQ:SLS) with a Overweight rating and announces Price Target of $18.
SELLAS Life Sciences Group 8K Shows Co. Had $32M In Cash, Cash Equivalents, 15.8M Shares Of Common Stock Outstanding; Says Including 421K Shares Sold To Co.’s Controlled Equity Offering Sales Agreement With Cantor Fitzgerald, Priced At $13.15/Share
July 7, 4:52 PM
July 1, 12:43 PM